Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Flebogamma DIF (previously Flebogammadif)

Flebogamma DIF 50 mg/ml solution for infusion · Abschnitt 4.8 · PDF-Seite 11

HOS-117931 · Präparat HOS-094719

Frequency Frequency MedDRA System Organ Adverse reaction per per Class (SOC) patient infusion Infections and infestations Nasopharyngitis Uncommon Uncommon Immune system disorders Hypersensitivity Uncommon Rare Psychiatric disorders Abnormal behaviour Uncommon Rare Migraine Uncommon Rare Nervous system disorders Headache Very Common Common Dizziness Common Uncommon Tachycardia Common Common Cardiac disorders Cardiovascular disorder Uncommon Rare Hypertension Common Uncommon Diastolic hypertension Common Uncommon Systolic hypertension Uncommon Uncommon Vascular disorders Hypotension Common Common Diastolic hypotension Common Common Blood pressure fluctuation Uncommon Rare Flushing Uncommon Rare Bronchitis Common Uncommon Dyspnoea Uncommon Rare Asthma Uncommon Rare Epistaxis Uncommon Rare Respiratory, thoracic and Productive cough Uncommon Uncommon mediastinal disorders Cough Uncommon Rare Wheezing Common Uncommon Laryngeal pain Uncommon Rare Nasal discomfort Uncommon Rare Diarrhoea Common Uncommon Vomiting Common Uncommon Gastrointestinal disorders Abdominal pain upper Common Uncommon Abdominal pain Common Uncommon Nausea Common Uncommon Rash pruritic Uncommon Uncommon Dermatitis contact Uncommon Rare Skin and subcutaneous tissue Urticaria Common Uncommon disorders Pruritus Uncommon Uncommon Rash Uncommon Rare Hyperhidrosis Uncommon Rare

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.